| COVID-19 |
1 |
1 |
| Brain |
0 |
0.66 |
| Hospital |
0 |
0.57 |
| Depression |
0 |
0.8 |
| Memory |
0 |
0.33 |
| Headache |
0 |
0.3 |
| Post-Traumatic Stress Disorder |
0 |
0.85 |
| Cardiovascular Risk Management |
0 |
0.25 |
| Cognitive Deficits |
0 |
0.95 |
| Anxiety |
0 |
0.6 |
| Dyslipidemia |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Exercise |
0 |
0.08 |
| Hypogeusia |
0 |
0.08 |
| Hyposmia |
0 |
0.08 |
| Magnetic Resonance Imaging |
0 |
0.08 |
| Neuroimaging |
0 |
0.08 |
| Neuroinflammation |
0 |
0.08 |
| Noninvasive Ventilation |
0 |
0.08 |
| Smoking |
0 |
0.08 |
| Anxiety Disorder |
0 |
0.07 |
| Erectile Dysfunction |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Lipids Management |
0 |
0.07 |
| Mechanical Ventilation |
0 |
0.07 |
| Tobacco Cessation |
0 |
0.07 |